Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants.

Saved in:
Bibliographic Details
Title: Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants.
Authors: de Andrade KC; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: kelvin.deandrade@nih.gov., Strande NT; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA., Kim J; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Haley JS; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA., Hatton JN; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Frone MN; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Khincha PP; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Thone GM; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA., Mirshahi UL; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA., Schneider C; Division of Hematology/Oncology, Department of Medicine and Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Desai H; Division of Hematology/Oncology, Department of Medicine and Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Dove JT; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA., Smelser DT; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA., Levine AJ; Simons Center for Systems Biology, Institute for Advanced Study, Princeton, NJ, USA., Maxwell KN; Division of Hematology/Oncology, Department of Medicine and Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Stewart DR; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Carey DJ; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA., Savage SA; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Corporate Authors: Penn Medicine BioBank, Regeneron Genetics Center
Source: HGG advances [HGG Adv] 2024 Jan 11; Vol. 5 (1), pp. 100242. Date of Electronic Publication: 2023 Sep 29.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101772885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-2477 (Electronic) Linking ISSN: 26662477 NLM ISO Abbreviation: HGG Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-2477
DOI:10.1016/j.xhgg.2023.100242